Filing metadata

Accession number
0001178913-22-002093
Form type
Form 4
Filer
Chemomab Therapeutics Ltd.
CIK
CIK 1534248
Filed
May 19, 2022
Reporting period
May 18, 2022
Description
Insider transaction

Explore SEC Filings Hub